The YURiA-PHARM Group Implements LifeSphere®

The YURiA-PHARM Group, in partnership with the technology company ArisGlobal, has implemented LifeSphere^® Regulatory, enabling the preparation of electronic dossiers.

This implementation enhances our regulatory readiness across target markets and makes the management of registration data faster and more accurate.

Nataliia Litvinenko, Research and Development Director at YURiA-PHARM said: “Implementing LifeSphere^® RIMS confirms our consistent efforts to modernize regulatory processes. This comprehensive platform supports our teams’ day-to-day operations and aligns with our long-term strategic objectives.”

This project is more than just a new IT system deployment. It is a prime example of using external constraints, particularly changing regulatory requirements, as a catalyst for operational transformation, implementing these changes with the help of advanced technologies.